{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:51:46Z","timestamp":1781571106065,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Beijing Major Epidemic Prevention and Control Key Specialty Intensive Care Medicine Construction Project under Grant","award":["010086"],"award-info":[{"award-number":["010086"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-05007-8","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T06:27:00Z","timestamp":1777098420000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The correlation between cardiac structure and renal function deterioration in patients with metabolic kidney disease: a cohort study"],"prefix":"10.1186","volume":"27","author":[{"given":"Rui","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaiqi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"issue":"4S","key":"5007_CR1","first-page":"S117","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117\u2013314.","journal-title":"Kidney Int"},{"issue":"10225","key":"5007_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","unstructured":"GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709\u201333.","journal-title":"Lancet"},{"key":"5007_CR3","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.kint.2025.01.044","volume":"108","author":"A Bansal","year":"2025","unstructured":"Bansal A, Chonchol M. Metabolic dysfunction-associated kidney disease: pathogenesis and clinical manifestations. Kidney Int. 2025;108:194\u2013200.","journal-title":"Kidney Int"},{"key":"5007_CR4","doi-asserted-by":"crossref","unstructured":"Zaitoon H, Abdul-Ghani M, DeFronzo RA. Insulin resistance and hyperinsulinaemia in kidney disease: mechanisms and metabolic effects. Nat Rev Nephrol. 2026.","DOI":"10.1038\/s41581-026-01066-0"},{"key":"5007_CR5","doi-asserted-by":"publisher","first-page":"1179834","DOI":"10.3389\/fmed.2023.1179834","volume":"10","author":"H Kataoka","year":"2023","unstructured":"Kataoka H, Nitta K, Hoshino J. Glomerular hyperfiltration and hypertrophy: an evaluation of maximum values in pathological indicators to discriminate diseased from normal. Front Med (Lausanne). 2023;10:1179834.","journal-title":"Front Med (Lausanne)"},{"key":"5007_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2478\/dine-2023-0001","volume":"3","author":"M Yang","year":"2023","unstructured":"Yang M, Liu Y, Luo S, Xiao Y. Zhao CaS and Lin. Renal lipid deposition and diabetic nephropathy. Diabet Nephrop. 2023;3:17\u201324.","journal-title":"Diabet Nephrop"},{"issue":"9","key":"5007_CR7","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1097\/HJH.0000000000003484","volume":"41","author":"K Kohagura","year":"2023","unstructured":"Kohagura K, Satoh A, Kochi M, et al. Urate-lowering drugs for chronic kidney disease with asymptomatic hyperuricemia and hypertension: a randomized trial. J Hypertens. 2023;41(9):1420\u20138.","journal-title":"J Hypertens"},{"issue":"12","key":"5007_CR8","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1093\/ndt\/gfad116","volume":"38","author":"A Candellier","year":"2023","unstructured":"Candellier A, Bohbot Y, Pasquet A, et al. Chronic kidney disease is a key risk factor for aortic stenosis progression. Nephrol Dial Transpl. 2023;38(12):2776\u201385.","journal-title":"Nephrol Dial Transpl"},{"key":"5007_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.amjcard.2021.03.056","volume":"151","author":"G Gan","year":"2021","unstructured":"Gan G, Bhat A, Kadappu KK, et al. Usefulness of Left Atrial Strain to Predict End Stage Renal Failure in Patients With Chronic Kidney Disease. Am J Cardiol. 2021;151:105\u201313.","journal-title":"Am J Cardiol"},{"key":"5007_CR10","doi-asserted-by":"publisher","first-page":"42578","DOI":"10.1038\/srep42578","volume":"7","author":"JC Huang","year":"2017","unstructured":"Huang JC, Chen SC, Tsai YC, et al. Prognostic Significance of Left Ventricular Mass Index and Renal Function Decline Rate in Chronic Kidney Disease G3 and G4. Sci Rep. 2017;7:42578.","journal-title":"Sci Rep"},{"issue":"33","key":"5007_CR11","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021\u2013104.","journal-title":"Eur Heart J"},{"key":"5007_CR12","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022. 45(Suppl 1): S17-S38.","DOI":"10.2337\/dc22-S002"},{"issue":"10","key":"5007_CR13","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.ophtha.2018.04.007","volume":"125","author":"TY Wong","year":"2018","unstructured":"Wong TY, Sun J, Kawasaki R, et al. Guidelines on Diabetic Eye Care: The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings. Ophthalmology. 2018;125(10):1608\u201322.","journal-title":"Ophthalmology"},{"issue":"4S","key":"5007_CR14","first-page":"S1","volume":"98","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group","year":"2020","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2020;98(4S):S1\u2013115.","journal-title":"Kidney Int"},{"key":"5007_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrneph.2016.75","volume":"12","author":"VD D\u2019Agati","year":"2016","unstructured":"D\u2019Agati VD, Chagnac A, de Vries AP, Levi M, Porrini E, Herman-Edelstein M, et al. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat Rev Nephrol. 2016;12:453\u201371.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"5007_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2018.06.004","volume":"32","author":"C Mitchell","year":"2019","unstructured":"Mitchell C, Rahko PS, Blauwet LA, et al. Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr. 2019;32(1):1\u201364.","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"5007_CR17","doi-asserted-by":"publisher","first-page":"2593732","DOI":"10.1080\/0886022X.2025.2593732","volume":"47","author":"S Anumas","year":"2025","unstructured":"Anumas S, Rattanapanop P, Pattharanitima P. Predictors of rapid eGFR decline in early to moderate chronic kidney disease (stages G1-G4): insights from a real-world Thai cohort incorporating KDIGO 2024 guidelines. Ren Fail. 2025;47(1):2593732.","journal-title":"Ren Fail"},{"issue":"10","key":"5007_CR18","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1093\/ndt\/gfaa234","volume":"35","author":"DC Wheeler","year":"2020","unstructured":"Wheeler DC, Stefansson BV, Batiushin M, et al. The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics. Nephrol Dial Transpl. 2020;35(10):1700\u201311.","journal-title":"Nephrol Dial Transpl"},{"issue":"23","key":"5007_CR19","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","volume":"383","author":"GL Bakris","year":"2020","unstructured":"Bakris GL, Agarwal R, Anker SD, et al. Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. N Engl J Med. 2020;383(23):2219\u201329.","journal-title":"N Engl J Med"},{"issue":"3","key":"5007_CR20","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/ndt\/gfae085","volume":"40","author":"AL Faucon","year":"2025","unstructured":"Faucon AL, Lundberg S, Lando S, et al. Albuminuria predicts kidney events in IgA nephropathy. Nephrol Dial Transpl. 2025;40(3):465\u201374.","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"5007_CR21","first-page":"21","volume":"15","author":"C Zoccali","year":"2025","unstructured":"Zoccali C. A New Clinical Entity Bridging the Cardiovascular System and the Kidney: The Chronic Cardiovascular-Kidney Disorder. Cardiorenal Med. 2025;15(1):21\u20138.","journal-title":"Cardiorenal Med"},{"issue":"3","key":"5007_CR22","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1053\/j.ajkd.2018.02.363","volume":"72","author":"N Bansal","year":"2018","unstructured":"Bansal N, Roy J, Chen HY, et al. Evolution of Echocardiographic Measures of Cardiac Disease From CKD to ESRD and Risk of All-Cause Mortality: Findings From the CRIC Study. Am J Kidney Dis. 2018;72(3):390\u20139.","journal-title":"Am J Kidney Dis"},{"key":"5007_CR23","doi-asserted-by":"crossref","unstructured":"Erratum Regarding. Evolution of Echocardiographic Measures of Cardiac Disease From CKD to ESRD and Risk of All-Cause Mortality: Findings From the CRIC Study (Am J Kidney Dis. 2018;72[3]:390\u2013399). Am J Kidney Dis. 2020. 75(5): 817.","DOI":"10.1053\/j.ajkd.2020.02.435"},{"key":"5007_CR24","doi-asserted-by":"crossref","unstructured":"Piechocki M, Przew\u0142ocki T, Pieni\u0105\u017cek P, Trystu\u0142a M, Podolec J, Kab\u0142ak-Ziembicka AA, Non-Coronary. Peripheral arterial atherosclerotic disease (Carotid, Renal, Lower Limb) in elderly patients: a review. PART II-pharmacological approach for management of elderly patients with peripheral atherosclerotic lesions outside coronary territory. J Clin Med. 2024; 13.","DOI":"10.3390\/jcm13051508"},{"issue":"5","key":"5007_CR25","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1056\/NEJMoa1810742","volume":"380","author":"IC Macdougall","year":"2019","unstructured":"Macdougall IC, White C, Anker SD, et al. Intravenous Iron in Patients Undergoing Maintenance Hemodialysis. N Engl J Med. 2019;380(5):447\u201358.","journal-title":"N Engl J Med"},{"issue":"6","key":"5007_CR26","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/jbmr.4272","volume":"36","author":"ML Noonan","year":"2021","unstructured":"Noonan ML, Ni P, Agoro R, et al. The HIF-PHI BAY 85-3934 (Molidustat) Improves Anemia and Is Associated With Reduced Levels of Circulating FGF23 in a CKD Mouse Model. J Bone Min Res. 2021;36(6):1117\u201330.","journal-title":"J Bone Min Res"},{"issue":"12","key":"5007_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2024.0474","volume":"85","author":"J Xu","year":"2024","unstructured":"Xu J, Jia X, Zhang X, et al. Correlation between Serum Biomarkers and Disease Progression of Chronic Kidney Disease. Br J Hosp Med (Lond). 2024;85(12):1\u201314.","journal-title":"Br J Hosp Med (Lond)"},{"key":"5007_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12012-025-10086-4","volume":"26","author":"A Awashra","year":"2026","unstructured":"Awashra A, AbuBaha M, Mahafdah B, AbuBaha B, Aldwaik S, Khaled A, et al. Iron Balance and Cardiovascular Health: The Double-Edged Role of Deficiency and Overload. Cardiovasc Toxicol. 2026;26:9.","journal-title":"Cardiovasc Toxicol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05007-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05007-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05007-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:52:31Z","timestamp":1781567551000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05007-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5007"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05007-8","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"28 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the Ethics Committee of Peking University Third Hospital (M2024876). This study was conducted in accordance with the Declaration of Helsinki. The requirement for individual informed consent was waived by the ethics committee due to the retrospective nature of the study, the analysis of deidentified data, and the minimal risk to participants. All patient data were anonymized and protected according to institutional protocols. The study adhered to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines for cohort studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"362"}}